wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
1940-6207.CAPR-14-0148
1940-6207.CAPR-14-0148
http://dx.doi.org/10.1158/1940-6207.CAPR-14-0148
A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum
P356
Q35163569-A0C488CA-AC1D-4A09-86CB-E55345583F15
P356
1940-6207.CAPR-14-0148
http://dx.doi.org/10.1158/1940-6207.CAPR-14-0148